Samalin Investment Counsel, LLC Elevance Health, Inc. Transaction History

Samalin Investment Counsel, LLC

$274 Million
Q3 2025

A detailed history of Samalin Investment Counsel, LLC transactions in Elevance Health, Inc. stock. As of the latest transaction made, Samalin Investment Counsel, LLC holds 836 shares of ELV stock, worth $272,393. This represents 0.1% of its overall portfolio holdings.

Number of Shares

836

Previous 905 7.62%

Holding current value

$272,393

Previous $352,000 23.3%

% of portfolio

0.1%

Previous 0.14%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	SELL	$274.66 - $395.76 $18,951 - $27,307	-69 Reduced 7.62%	836 $270,000
Q2 2025 Aug 07, 2025	SELL	$372.27 - $452.69 $14,518 - $17,654	-39 Reduced 4.13%	905 $352,000
Q1 2025 May 14, 2025	BUY	$365.9 - $436.25 $42,078 - $50,168	115 Added 13.87%	944 $410,000
Q4 2024 Feb 11, 2025	SELL	$365.96 - $514.62 $17,200 - $24,187	-47 Reduced 5.37%	829 $306,000
Q3 2024 Nov 13, 2024	BUY	$500.12 - $562.29 $1,000 - $1,124	2 Added 0.23%	876 $455,000

Q2 2024 Aug 13, 2024	BUY	$497.49 - $547.8 $6,964 - $7,669	14 Added 1.63%	874 $473,000
Q1 2024 May 13, 2024	SELL	$464.61 - $519.96 $104,537 - $116,991	-225 Reduced 20.74%	860 $445,000
Q4 2023 Feb 14, 2024	BUY	$433.51 - $488.06 $8,670 - $9,761	20 Added 1.88%	1,085 $511,000
Q3 2023 Nov 13, 2023	SELL	$414.13 - $475.93 $4,969 - $5,711	-12 Reduced 1.11%	1,065 $463,000
Q2 2023 Aug 03, 2023	BUY	$436.33 - $496.2 $156,642 - $178,135	359 Added 50.0%	1,077 $478,000
Q1 2023 May 09, 2023	BUY	$446.3 - $502.2 $1,785 - $2,008	4 Added 0.56%	718 $330,000
Q3 2022 Nov 10, 2022	SELL	$445.98 - $507.0 $13,379 - $15,210	-30 Reduced 4.03%	714 $324,000
Q1 2022 Oct 13, 2022	BUY	$428.44 - $502.48 $81,832 - $95,973	191 Added 34.54%	744 $365,000
Q1 2022 May 16, 2022	BUY	$428.44 - $502.48 $81,832 - $95,973	191 Added 34.54%	744 $365 Million
Q4 2021 Oct 13, 2022	BUY	$370.08 - $467.67 $4,811 - $6,079	13 Added 2.41%	553 $257,000
Q4 2021 Feb 15, 2022	BUY	$370.08 - $467.67 $8,141 - $10,288	22 Added 4.14%	553 $257 Million
Q3 2021 Nov 15, 2021	SELL	$357.51 - $398.13 $3,217 - $3,583	-9 Reduced 1.67%	531 $198 Million
Q2 2021 Oct 13, 2022	SELL	$352.19 - $401.9 $71,846 - $81,987	-204 Reduced 27.42%	540 $207,000
Q2 2021 Aug 12, 2021	BUY	$352.19 - $401.9 $190,182 - $217,026	540 New	540 $206,000
Q1 2021 May 11, 2021	SELL	$287.7 - $371.31 $141,260 - $182,313	-491 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$270.17 - $333.15 $19,452 - $23,986	-72 Reduced 12.79%	491 $158 Million
Q3 2020 Nov 10, 2020	BUY	$245.73 - $284.63 $138,345 - $160,246	563 New	563 $151,000
Q1 2020 May 04, 2020	SELL	$174.68 - $307.74 $64,631 - $113,863	-370 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$234.82 - $306.42 $86,883 - $113,375	370 New	370 $111,000

Others Institutions Holding ELV

# of Institutions

1,782

Shares Held

199M

Call Options Held

2.38M

Put Options Held

2.17M

View Full List

About Elevance Health, Inc.

Ticker ELV
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Shares Outstandng 240,000,992
Market Cap $78.2B
Description
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....

More about ELV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samalin Investment Counsel, LLC with notifications on news.

Account

Samalin Investment Counsel, LLC Elevance Health, Inc. Transaction History